Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS)
CNY 26.05
(0.35%)
CNY 26.05
(0.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 41.39 Billion | 43.95 Billion | 39 Billion | 30.3 Billion | 28.58 Billion | 24.91 Billion |
| Cost of Revenue | 21.59 Billion | 23.16 Billion | 20.22 Billion | 13.43 Billion | 11.54 Billion | 10.36 Billion |
| Gross Profit | 19.8 Billion | 20.78 Billion | 18.77 Billion | 16.87 Billion | 17.04 Billion | 14.55 Billion |
| Operating Expenses | 17.16 Billion | 17.14 Billion | 16.05 Billion | 14.04 Billion | 14.42 Billion | 12.18 Billion |
| Selling, General and Administrative Expenses | 13.3 Billion | 10.15 Billion | 9.94 Billion | 9.4 Billion | 10.71 Billion | 9.18 Billion |
| Research and Development Expenses | 3.73 Billion | 4.3 Billion | 3.83 Billion | 2.79 Billion | 2.04 Billion | 1.47 Billion |
| Other Expenses | - | 2.68 Billion | 2.27 Billion | 1.84 Billion | 1.66 Billion | 44.05 Million |
| Cost and Expenses | 40.28 Billion | 40.31 Billion | 36.28 Billion | 27.47 Billion | 25.96 Billion | 22.55 Billion |
| Operating Income | 3.3 Billion | 8.29 Billion | 6.31 Billion | 4.72 Billion | 6.41 Billion | 3.53 Billion |
| Interest Expense | 1.32 Billion | 963.8 Million | 822.53 Million | 880.95 Million | 1.07 Billion | 929.65 Million |
| Income Tax Expense | 369.5 Million | 626.91 Million | 1.06 Billion | 737.86 Million | 782.23 Million | 559.71 Million |
| Earnings before Tax | 1.07 Billion | 4.57 Billion | 6.05 Billion | 4.67 Billion | 4.52 Billion | 3.57 Billion |
| Net Income | 2.38 Billion | 3.73 Billion | 4.72 Billion | 3.66 Billion | 3.32 Billion | 2.7 Billion |
| Earnings Per Share Basic | 0.89 | 1.43 | 1.85 | 1.43 | 1.30 | 1.07 |
| Earnings Per Share Diluted | 0.89 | 1.43 | 1.85 | 1.43 | 1.30 | 1.07 |
| Weighted Average Shares Outstanding | 2.68 Billion | 2.6 Billion | 2.56 Billion | 2.56 Billion | 2.56 Billion | 2.52 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.68 Billion | 2.6 Billion | 2.56 Billion | 2.56 Billion | 2.56 Billion | 2.53 Billion |
| Gross Margin | 0.48 | 0.47 | 0.48 | 0.56 | 0.60 | 0.58 |
| EBIT Margin | 0.13 | 0.24 | 0.24 | 0.23 | 0.28 | 0.23 |
| Profit Margin | 0.06 | 0.08 | 0.12 | 0.12 | 0.12 | 0.11 |
| EBITDA | 5.55 Billion | 7.87 Billion | 7.05 Billion | 5.72 Billion | 7.07 Billion | 4.54 Billion |
| Earnings Before Tax Margin | 0.08 | 0.19 | 0.16 | 0.16 | 0.22 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 10.44 Billion | 10.23 Billion | 10.06 Billion | 41.12 Billion | 10.62 Billion | 9.3 Billion |
| Cost of Revenue | 5.42 Billion | 5.73 Billion | 5.07 Billion | 23.12 Billion | 6.24 Billion | 5.08 Billion |
| Gross Profit | 5.02 Billion | 4.49 Billion | 4.98 Billion | 18 Billion | 4.38 Billion | 4.22 Billion |
| Operating Expenses | 4.15 Billion | 3.81 Billion | 4.08 Billion | 17.16 Billion | 4.43 Billion | 4.26 Billion |
| Selling, General and Administrative Expenses | 6.59 Billion | 2.85 Billion | 3.25 Billion | - | 3.49 Billion | 4.78 Billion |
| Research and Development Expenses | 786.3 Million | 937.02 Million | 829.56 Million | - | 1.01 Billion | 1.02 Billion |
| Other Expenses | -3.22 Billion | -26.05 Million | 5.88 Million | -124.69 Million | 71.16 Million | -53.62 Million |
| Cost and Expenses | 9.58 Billion | 9.55 Billion | 9.16 Billion | 40.28 Billion | 10.67 Billion | 9.34 Billion |
| Operating Income | 1.17 Billion | 680.04 Million | 904.51 Million | 844.06 Million | -51.31 Million | 659.58 Million |
| Interest Expense | 358.33 Million | 361.45 Million | 348.09 Million | 1.32 Billion | 377.16 Million | 344.29 Million |
| Income Tax Expense | 171.57 Million | 149.26 Million | 232.2 Million | 369.5 Million | -269.14 Million | 28.4 Million |
| Earnings before Tax | 1.14 Billion | 401.78 Million | 688.09 Million | 1.07 Billion | -716.81 Million | 636.98 Million |
| Net Income | 785.84 Million | 615.06 Million | 609.73 Million | 2.38 Billion | 103.19 Million | 505.59 Million |
| Earnings Per Share Basic | 0.30 | 0.23 | 0.23 | - | 0.04 | 0.19 |
| Earnings Per Share Diluted | 0.30 | 0.23 | 0.23 | - | 0.04 | 0.19 |
| Weighted Average Shares Outstanding | 2.66 Billion | 2.67 Billion | 2.67 Billion | 2.66 Billion | 2.67 Billion | 2.67 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.66 Billion | 2.67 Billion | 2.67 Billion | 2.66 Billion | 2.67 Billion | 2.67 Billion |
| Gross Margin | 0.48 | 0.44 | 0.50 | 0.44 | 0.41 | 0.45 |
| EBIT Margin | 0.14 | 0.14 | 0.14 | - | 0.07 | 0.08 |
| Profit Margin | 0.08 | 0.06 | 0.06 | 0.06 | 0.01 | 0.05 |
| EBITDA | 1.49 Billion | 1.43 Billion | 1.39 Billion | - | 744.48 Million | 748.65 Million |
| Earnings Before Tax Margin | 0.11 | 0.07 | 0.09 | 0.02 | -0.00 | 0.07 |
VAN
VBIND
0309
BIM
002062
AGFY